All Merck & Co articles – Page 3
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
BusinessAmid huge cuts, Merck vows research focus
8500 more jobs to be axed, but the drugmaker ‘remains committed to innovation’
-
Business
Aspen acquires anticoagulant brands
South African drugmaker buys thrombosis drugs from GSK for £700m
-
Business
Aspen in $1 billion deal with Merck & Co
South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
Business
Laropiprant recalled
Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
-
Business
Nasonex patent ruling goes against Merck & Co
The court ruled that the Merck patent was valid - but Apotex won’t infringe it with its product
-
Business
Good signs for Merck & Co insomnia pill
Suvorexant switches off wakefulness to help patients drop off quicker and stay asleep longer
-
Business
More testing needed for ridaforolimus
Marketing approval for anti-cancer drug ridaforolimus has been held up in the US
- Previous Page
- Page1
- Page2
- Page3
- Next Page